Keyword: NewLink Genetics

News

Genentech Returns Cancer Drug Rights to NewLink

16.06.2017 - US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...

News

GAVI and US Merck Link on Ebola Vaccine

27.01.2016 - Geneva, Switzerland-based GAVI (Global Alliance for Vaccines and Immunization), a public-private partnership, and Merck Sharp & Dohme (MSD), known in the US as Merck & Co, have...

News

GSK’s Ebola Vaccine Fast-tracked Into Clinical Trials

29.08.2014 - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into clinical trials with human patients, and the company plans to immediately begin building a stockpile...